Shirshikov, F. V.
Bespyatykh, J. A.
Article History
Received: 21 February 2023
Revised: 10 March 2023
Accepted: 11 March 2023
First Online: 23 November 2023
ETHICS APPROVAL AND CONSENT TO PARTICIPATE
: This article does not contain any studies conducted by any authors of this work. This article does not contain any studies involving patients or animals as test objects. Informed consent was not required for this article. Nucleotide sequences from the TB2341 primer set has been used in the patent claim for invention to the ROSPATENT: reg. no. 2022133809 from 22.12.2022 (authors: S.F.V., B.J.A.).